You are here

  • Home
  • Archive
  • Volume 27, Issue Suppl 1
  • 3PC-045 Impact of the preparation of a clinical solution of rituximab 1.0 mg/mL on the particulates (aggregation) measured by dynamic light scattering: sodium chloride and glucose concentration, and agitation effect

Article info

Article menu

Download PDFPDF

Section 3: Production and Compounding
3PC-045 Impact of the preparation of a clinical solution of rituximab 1.0 mg/mL on the particulates (aggregation) measured by dynamic light scattering: sodium chloride and glucose concentration, and agitation effect

Authors

Citation

Natalia-Iglesias N, Hermosilla J, Exposito J, et al
3PC-045 Impact of the preparation of a clinical solution of rituximab 1.0 mg/mL on the particulates (aggregation) measured by dynamic light scattering: sodium chloride and glucose concentration, and agitation effect
European Journal of Hospital Pharmacy 2020;27:A43.

Publication history

  • First published March 24, 2020.
Online issue publication 
August 05, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.